During the past decade, PARC Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PARC Clinical Research" #1 sponsor was "PTC Therapeutics" with 2 trials, followed by "Reneo Pharma Ltd" with 2 trials sponsored, "BioAge Labs, Inc." with 1 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored and "CSL Behring" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PARC Clinical Research" #1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator, "Novotech (Australia) Pty Limited" with 1 trials as a collaborator, "Royal Adelaide Hospital" with 1 trials as a collaborator, "Southern Star Research Pty Ltd." with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "PARC Clinical Research" are "Phenylketonuria" (2 trials), "Primary Mitochondrial Myopathy" (2 trials), "Anemia" (1 trials), "Diffuse Cutaneous Systemic Sclerosis" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "PARC Clinical Research" in a lesser frequency.

Most popular intervention types in "PARC Clinical Research" are "Drug" (9 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "PTC923" (2 trials), "REN001" (2 trials), "40 mg Laninamivir Octanoate" (1 trials) and "80 mg Laninamivir Octanoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "PARC Clinical Research" are 11 trials for "All" genders.

Currently, there are NaN active trials in "PARC Clinical Research". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in PARC Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PARC Clinical Research, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".